BCL6-IN-7

• CAT Number: I023061
• CAS Number: 2097518-46-0
• Molecular Formula: C18H15ClN6O
• Molecular Weight: 366.80
• Purity: ≥95%
• Synonyms: 5-[[5-chloro-2-(pyridin-3-ylmethylamino)pyrimidin-4-yl]amino]-1,3-dihydroindol-2-one
• InChI: InChI=1S/C18H15ClN6O/c19-14-10-22-18(21-9-11-2-1-5-20-8-11)25-17(14)23-13-3-4-15-12(6-13)7-16(26)24-15/h1-6,8,10H,7,9H2,(H,24,26)(H2,21,22,23,25)
• InChIKey: MUSYPBPUEKXCSS-UHFFFAOYSA-N
• SMILES: C1C2=C(C=CC(=C2)NC3=NC(=NC=C3Cl)NCC4=CN=CC=C4)NC1=O

BCL6-IN-7（Cat No.:I023061）is a selective small molecule inhibitor designed to target B-cell lymphoma 6 (BCL6), a transcription factor implicated in the regulation of immune cell differentiation, particularly in B cells. BCL6 is associated with the development of various cancers, including B-cell lymphomas, and plays a role in immune evasion and tumor progression. By inhibiting BCL6, BCL6-IN-7 aims to disrupt cancer cell survival and proliferation. Preclinical studies suggest that BCL6-IN-7 has potential as a therapeutic agent for lymphoma and other cancers, providing a targeted approach to cancer treatment with minimal side effects.